Objective assessment of attention difficulties in adults with Attention-Deficit Hyperactivity Disorder (ADHD) - Objective assessment of attention difficulties in adult ADHD 1

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-002897-31-GB

Enrollment

Registered

2005-07-22

Start date

2006-04-04

Completion date

Unknown

Last updated

2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit Hyperactivity Disorder (ADHD) in Adults

Interventions

Trade Name: Ritalin Product Name: Methylphenidate Pharmaceutical Form: Tablet INN or Proposed INN: Methylphenidate Hydrochloride Concentration unit: mg milligram(s) Concentration type: up to Concentra

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adults, ADHD diagnosis, normal hearing, normal or corrected to normal vision Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Current history of neurological and/or psychiatric disorders, history of movement disorders, epilepsy, current use of MAO inhibitors or coumarin anticoagulants, drug abuse, problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption, severe hypertension, cardiac arrhythmia, angina pectoris, hyperthyroidism, glaucoma, thyrotoxicosis, pregnancy, severe hand motor deficit

Design outcomes

Primary

Measure	Time frame
Main Objective: To provide an objective tool for the diagnosis and treatment monitoring of ADHD.;Secondary Objective: To improve the diagnosis and treatment of ADHD in adulthood, and throught it, the quality of life of these patients and their families.;Primary end point(s): Normalisation of event-related brain potentials (ERPs), improved behavioural measures	—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026